Evidence-based guideline on the primary care management of asthma

Family Practice

Volumn 18, Issue 2, 2001, Pages 223-229

  Eccles, Martin ^a   Rousseau, Nikki ^a   Higgins, Bernard ^b   Thomas, Lois ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Asthma; Clinical guideline

Indexed keywords

ALLERGEN; ANTIASTHMATIC AGENT; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FORMOTEROL; LEUKOTRIENE RECEPTOR STIMULATING AGENT; NEDOCROMIL; NICOTINE; PLACEBO; SALMETEROL; THEOPHYLLINE;

ACUPUNCTURE; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDICATION; EVIDENCE BASED MEDICINE; GENERAL PRACTICE; HOMEOPATHY; HUMAN; MEDICAL INFORMATION; METERED DOSE INHALER; PATIENT CARE; PATIENT EDUCATION; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RISK ASSESSMENT; RISK FACTOR; SELF HELP; SIDE EFFECT; SMOKING; UNITED KINGDOM; YOGA;

EID: 0035074797     PISSN: 02632136     EISSN: None     Source Type: Journal    
DOI: 10.1093/fampra/18.2.223     Document Type: Article

References (67)

1. North of England evidence based guidelines development project: Summary version of evidence based guideline for the primary care management of asthma in adults
2. Guidelines on the management of asthma
3. Serevent nationwide surveillance study: Comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment
4. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma
5. The duration of action of inhaled formoterol dry powder
6. A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients
7. Salmeterol in nocturnal asthma: A double blind, placebo controlled trial of a long acting inhaled beta 2 agonist
8. Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease - A 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with (50 micrograms)
9. Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies
10. Salmeterol versus formoterol in patients with moderately severe asthma: Onset and duration of action
11. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group
12. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma
13. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients
14. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma
15. Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care
16. Efficacy and tolerance of a 12-week treatment with inhaled formoterol in patients with reversible obstructive lung disease
17. Quality of life in asthma clinical trials: Comparison of salmeterol and salbutamol
18. Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, Fwith formoterol
19. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: A Canadian multicenter study
20. A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma
21. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids
22. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy
23. Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids
24. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators
25. Effect of long-term treatment with salmeterol on asthma control: A double-blind, randomised crossover study
26. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
27. Salmeterol compared with slow-release terbutaline in nocturnal asthma
28. Comparison of salmeterol with disodium cromoglycate in the treatment of adult asthma
29. Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group
30. Salmeterol versus theophylline in the treatment of asthma
31. Pranlukast, a novel leukotriene receptor antagonist: Results of the first European, placebo controlled, multicentre clinical study in asthma
32. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval
33. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma
34. Zafirlukast for symptomatic mild-to-moderate asthma: A 13-week multicenter study
35. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma
36. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group
37. Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids
38. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid
39. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial
40. A randomized controlled trial comparing zileuton with theophylline in moderate asthma
41. A controlled trial of real and simulated acupuncture in the management of chronic asthma
42. Acupuncture and asthma: A review of controlled trials
43. A reassessment of the additive scoring of health practices
44. Acupuncture for the treatment of asthma bronchiale. (Cochrane Review)
45. Homeopathy for chronic asthma (Cochrane Review)
46. Effect of yoga breathing exercises (pranayama) on airway reactivity in subjects with asthma
47. Effectiveness of steroid therapy in acute exacerbations of asthma: A meta analysis
48. The effectiveness of corticosteroids in the treatment of acute exacerbations of asthma: A meta-analysis of their effect on relapse following acute assessment (Cochrane Review)
49. The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids
50. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care
51. Aminophylline treatment in severe, acute asthma. A meta-analysis
52. Aminophylline therapy for acute bronchospastic disease in the emergency room
53. Aminophylline in the treatment of acute asthma when beta 2-adrenergics and steroids are provided
54. Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study
55. Comparison of holding chambers and nebulisers for beta-agonists in acute asthma
56. Emergency treatment of acute asthma with albuterol metered-dose inhaler plus holding chamber: How often should treatments be administered?
57. Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma
58. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma
59. The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma
60. House dust mite control measures for asthma
61. Allergen immunotherapy for asthma
62. Tobacco addiction module of the Cochrane Database of Systematic Reviews
63. Smoking cessation: What the health service can do
64. The effects of limited (information only) patient education programs on the health outcomes of adults with asthma
65. The effects of self-management education and regular practitioner review in adults with asthma